SCHEMBL7742896

SCHEMBL7742896

CC(=O)NCC(=O)N(C)c1ccc(Cl)c(COc2cccc3nc(C)cnc23)c1Cl

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BDKRB2 P30411 18/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7748415 0.93 BDKRB2 (0.76) BDKRB2
SCHEMBL7748022 0.88 BDKRB2 (0.63) BDKRB2
SCHEMBL7743013 0.86 BDKRB2 (0.77) BDKRB2
SCHEMBL7747838 0.85 BDKRB2 (0.71) BDKRB2
SCHEMBL7836548 0.84 BDKRB2 (1.00) BDKRB2
SCHEMBL7836550 0.84 BDKRB2 (1.00) BDKRB2
SCHEMBL7975710 0.82 BDKRB2 (0.71) BDKRB2
SCHEMBL7742871 0.82 BDKRB2 (0.57) BDKRB2
SCHEMBL7975566 0.82 BDKRB2 (0.71) BDKRB2
SCHEMBL7746927 0.81 BDKRB2 (0.59) BDKRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0622361-B1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO (JP) 2001-10-04 EP disclosed
US-6169095-B1 FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES IN THE EYE, SUCH AS ALLERGY, INFLAMMATION AND PAIN OF THE EYE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
US-5563162-A CAN BE ADMINISTERD FOR THE TREATMENT OF ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASES, SHOCK OR PAIN IN ANIMALS AND HUMANS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-08 US disclosed
EP-0622361-A1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-11-02 EP disclosed